Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity Revascularization

Author:

Hess Connie N.12,Szarek Michael23,Anand Sonia S.4,Bauersachs Rupert M.5,Patel Manesh R.6,Debus E. Sebastian7,Nehler Mark R.28,Capell Warren H.29,Beckman Joshua A.10,Piazza Gregory11,Henkin Stanislav12,Bura-Rivière Alessandra13,Lawall Holger14,Roztocil Karel15,Hsia Judith12,Muehlhofer Eva16,Berkowitz Scott D.1217,Haskell Lloyd P.18,Bonaca Marc P.12

Affiliation:

1. Division of Cardiology, Department of Medicine, University of Colorado School of Medicine, Aurora

2. CPC Clinical Research, Aurora, Colorado

3. The State University of New York Downstate Health Sciences University, Brooklyn

4. Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, Canada

5. Department of Vascular Medicine, Klinikum Darmstadt, Darmstadt, and Center for Thrombosis and Hemostasis, University of Mainz, Mainz, Germany

6. Duke Clinical Research Institute, Division of Cardiology, Duke University Medical Center, Durham, North Carolina

7. Department of Vascular Medicine, Vascular Surgery–Angiology–Endovascular Therapy, University of Hamburg-Eppendorf, Hamburg, Germany

8. University of Colorado School of Medicine, Department of Surgery, Aurora

9. Division of Endocrinology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora

10. Cardiovascular Division, Vanderbilt University Medical Center, Nashville, Tennessee

11. Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts

12. Heart and Vascular Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire

13. Toulouse University Hospital, Toulouse, France

14. Praxis für Herzkreislaufkrankheiten und Akademie für Gefäßkrankheiten, Ettlingen, Germany

15. Department of Transplantational Surgery, Institute of Clinical and Experimental Medicine, Prague, Czech Republic

16. Bayer, Research & Development, Wuppertal, Germany

17. Division of Hematology, Department of Medicine, University of Colorado School of Medicine, Aurora

18. Janssen Research and Development, Raritan, New Jersey

Publisher

American Medical Association (AMA)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3